Clinical Trial Update: Procalcitonin in Cirrhotic Patients at High Risk for Sepsis

View source ↗

Summary

A completed clinical trial investigating procalcitonin in cirrhotic patients at high risk for sepsis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Cirrhosis
• Sepsis

Snippet

Sponsor: Prof. Facchinetti Fabio | Conditions: Cirrhosis, Ascites | Status: COMPLETED